PPARGC1A and metabolic dysfunction-associated steatotic liver disease: This finding suggests that eRNAs may be involved in NAFLD progression, as both PGC1α and SIRT1 are implicated in fatty acid oxidation and NAFLD development (Rodgers et al., 2005; Bellanti et al., 2014; Choi et al., 2017).